
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Kailera Therapeutics (NASDAQ:KLRA) through any online brokerage.
Other companies in Kailera Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Kailera Therapeutics has a consensus price target of $38.00.
The stock price for Kailera Therapeutics (NASDAQ: KLRA) is $13.94 last updated September 11, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Kailera Therapeutics.
Kailera Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Kailera Therapeutics.
Kailera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.